Use of Angiotensin Converting Enzyme Inhibitors and Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer

被引：0

作者：

Kerns, S. L. ^{[1
]}

Morlang, A. ^{[1
]}

Lee, S. M. ^{[2
]}

Hall, W. A. ^{[3
]}

Peterson, D. ^{[4
]}

Marples, B. ^{[1
]}

Zhang, H. ^{[1
]}

Bylund, K. C. ^{[1
]}

Rosenzweig, D. ^{[1
]}

de Ruyck, K. ^{[5
]}

Rosenstein, B. S. ^{[6
]}

Gomez CaamaNo, A. ^{[7
]}

Vega, A. ^{[8
]}

Parker, C. ^{[9
,10
]}

West, C. M. L. ^{[11
]}

Janelsins, M. ^{[12
]}

Chen, Y. ^{[1
]}

Messing, E. ^{[13
]}

Morrow, G. ^{[12
]}

机构：

[1] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA

[2] Univ Rochester, Rochester, NY USA

[3] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA

[4] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA

[5] Univ Ghent, Ghent, Belgium

[6] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY USA

[7] H Clin Univ, Santiago De Compostela, Spain

[8] Univ Santiago de Compostela, Santiago De Compostela, Spain

[9] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[10] Inst Canc Res, Sutton, Surrey, England

[11] Univ Manchester, Manchester, Lancs, England

[12] Univ Rochester, Dept Surg, Canc Control, Rochester, NY USA

[13] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2566

引用

页码：E280 / E281

页数：2

共 50 条

[41] Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists
Vaquero Roncero, Luis Mario
Sanchez Poveda, David
Valdunciel Garcia, Joaquin Jose
Sanchez Barrado, Maria Elisa
Calvo Vecino, Jose Maria
JOURNAL OF CLINICAL ANESTHESIA, 2017, 40 : 91 - 98
[42] The urinary bladder angiotensin system: Response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors
WeaverOsterholtz, D
Reams, G
Wu, Z
Knaus, J
Campbell, F
Bauer, JH
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) : 603 - 609
[43] Risk of Lung Cancer With Concomitant Use of Angiotensin Converting Enzyme Inhibitors and Dipeptidyl Peptidase 4 Inhibitors: Population Based Cohort Study
Hong, Bin
Kim, Ju Hwan
Shin, Ju-Young
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 234 - 235
[44] Radiation pneumonitis with stereotactic body radiotherapy: effects of angiotensin converting enzyme inhibitors
Chundury, A.
Rehman, S.
Roach, M.
Mullen, D.
DeWeese, T.
Bradley, J.
Robinson, C.
RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S208 - S209
[45] Predictive Models of Bladder Toxicity in Prostate Cancer Radiotherapy
Zhu, J.
Simon, A.
Ospina, J. D.
Le Prise, E.
Bossi, A.
Chira, C.
Gnep, K.
Beckendorf, V.
Polet, V.
De Crevoisier, R.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S486 - S486
[46] Acute and Late Toxicity in Radical Radiotherapy for Bladder Cancer
Majewski, W.
Tarnawski, R.
CLINICAL ONCOLOGY, 2009, 21 (08) : 598 - 609
[47] Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients
Okaishi, K
Morimoto, S
Fukuo, K
Niinobu, T
Hata, S
Onishi, T
Ogihara, T
AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (08) : 778 - 783
[48] ANGIOTENSIN CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, CALCIUM CHANNEL BLOCKER USE AND THE RISK OF HEPATOCELLULAR CANCER: A NESTED COHORT ANALYSIS.
Menon, Shyam
Mathew, Ray
GASTROENTEROLOGY, 2020, 158 (06) : S237 - S237
[49] Parameters Impacting on Late Bladder Toxicity in Prostate Cancer 3D Conformal Radiotherapy
Le Prise, E.
Chira, C. I.
Lahbabi, K.
Bossi, A.
Vincendeau, S.
Vauleon, E.
Rossille, D.
Bayat, S.
Lafond, C.
de Crevoisier, R.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S322 - S323
[50] Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
Ataman, F
Zurlo, A
Artignan, X
van Tienhoven, G
Blank, LE
Warde, P
Dubois, JB
Jeanneret, W
Keuppens, F
Bernier, J
Kuten, A
Collette, L
Pierart, M
Bolla, M
EUROPEAN JOURNAL OF CANCER, 2004, 40 (11) : 1674 - 1681

← 1 2 3 4 5 →